The company's initial target is immuno-oncology projects but there are plans to expand into autoimmune disease, infectious disease, and more.

The annual application window typically opens in early November but will be “delayed indefinitely until the Trump Administration and Washington Republicans act to end the government shutdown and fund ...

AllOne Health Unveils Landmark Work/Life Study: Profile of 59,137 Real-World Cases Shows Wide Range of Everyday Needs Drive EAP Use—Legal, Financial, Life Assistance, and Personal Health. EAP is not ...

Some employers allow drinking in the office. Here's what businesses should consider when creating an office alcohol policy ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced its financial results for the fiscal ...

And yes, we're really excited not only with the performance we're seeing in terms of the number of enrollments coming in, but ...

Smart Assist: An AI companion and digital gateway into Smartsheet that helps users accelerate time-to-value by creating workspaces and projects from simple outlines, activating automations and ...

COVID-19 increased workplace stress through remote work isolation, long COVID accommodations, fear of infection and blurred work-life boundaries for employees.

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...

Proposition 50, also known as the Election Rigging Response Act, was approved by 63% of California voters on Nov. 4. Now that ...

By Dr. Ann Hawkins, Chief Innovation & Marketing Officer, Health Karma Group ...

Talkspace stock offers a strong risk/reward profile and >25% IRR potential amid robust earnings and B2B2C growth. Learn more about TALK stock here.